Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Primary Outcome Time Point (3 Weeks)	STARTED	Prednisone	181
Primary Outcome Time Point (3 Weeks)	STARTED	Placebo	88
Primary Outcome Time Point (3 Weeks)	COMPLETED	Prednisone	179
Primary Outcome Time Point (3 Weeks)	COMPLETED	Placebo	88
Primary Outcome Time Point (3 Weeks)	NOT COMPLETED	Prednisone	2
Primary Outcome Time Point (3 Weeks)	NOT COMPLETED	Placebo	0
Secondary Outcome Time Point (52 Weeks)	STARTED	Prednisone	179
Secondary Outcome Time Point (52 Weeks)	STARTED	Placebo	88
Secondary Outcome Time Point (52 Weeks)	COMPLETED	Prednisone	157
Secondary Outcome Time Point (52 Weeks)	COMPLETED	Placebo	77
Secondary Outcome Time Point (52 Weeks)	NOT COMPLETED	Prednisone	22
Secondary Outcome Time Point (52 Weeks)	NOT COMPLETED	Placebo	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00668434/flow